NDC00409-5093-11: CEFTAZIDIME FOR INJECTION.
The CEFTAZIDIME FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: POWDER, administration: INTRAVENOUS, features_provided: STERILE, primary_container_type: VIAL, supplementary_features: ADDVANTAGE VIALS TO BE USED WITH ADDVANTAGE DILUENT, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-528-6349, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| administration | INTRAVENOUS |
| special_features | STORE IN A DRY STATE, BETWEEN 15 AND 30 DEG. C; PROTECT FROM LIGHT; FOR IV USE; TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; TRAY OF 10S |
| features_provided | STERILE |
| primary_container_type | VIAL |
| supplementary_features | ADDVANTAGE VIALS TO BE USED WITH ADDVANTAGE DILUENT |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 18.000 MILLILITERS AFTER RECONSTITUTION |
| active_medicament_medicinal_strength | 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G |
| part_name_assigned_by_controlling_agency | CEFTAZIDIME F/INJ 2GM ADD-VANTAGE VIAL, 10'S |
| american_hospital_formulary_service_classification_number | 081206 |
| NSN | 6505-01-528-6349 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 18.000 MILLILITERS AFTER RECONSTITUTION |
| SUPPLEMENTARY FEATURES | ADDVANTAGE VIALS TO BE USED WITH ADDVANTAGE DILUENT |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | VIAL |
| PHYSICAL FORM | POWDER |
| SPECIAL FEATURES | STORE IN A DRY STATE, BETWEEN 15 AND 30 DEG. C; PROTECT FROM LIGHT; FOR IV USE; TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; TRAY OF 10S |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTAZIDIME F/INJ 2GM ADD-VANTAGE VIAL, 10'S |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 081206 |